Interventions to reduce Staphylococcus aureus in the management of atopic eczema

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2008, Pages

  Birnie, Andrew J ^a,c   Bath Hextall, Fiona J ^b   Ravenscroft, Jane Catherine ^a   Williams, Hywel C ^b  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETAMETHASONE; BETAMETHASONE VALERATE; BETAMETHASONE VALERATE PLUS FUSIDIC ACID; CEFADROXIL; CEFUROXIME AXETIL; CLOBETASOL; DIDECYLDIMETHYLAMMONIUM CHLORIDE; FARNESOL; FLUCLOXACILLIN; FLUOCINOLONE ACETONIDE; FLUOCINOLONE ACETONIDE PLUS NEOMYCIN SULPHATE; FUCIBET; GENTAMICIN; HALCINONIDE; HYDROCORTISONE; HYDROCORTISONE BUTYRATE; NEO SYNELAR; NEOMYCIN; NYSTATIN; OILATUM; OILATUM PLUS; POVIDONE IODINE; PREDNICARBATE; PREDNISOLONE; PSEUDOMONIC ACID; SILVER; TETRACYCLINE; TRIAMCINOLONE ACETONIDE; TRICLOCARBAN; UNCLASSIFIED DRUG; UNINDEXED DRUG; XYLITOL;

ATOPIC DERMATITIS; BACTERIAL COUNT; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; HUMAN; META ANALYSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; OUTCOME ASSESSMENT; PRURITUS; QUALITY OF LIFE; REMISSION; REVIEW; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT;

EID: 55049090902     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003871.pub2     Document Type: Review

References (75)

1. Boguniewicz 2001 {published data only} * Boguniewicz M, Sampson H, Leung SB, Harbeck R, Leung DYM. Effects of cefuroxime axetil on Staphylococcus aureus colonization and superantigen production in atopic dermatitis. Journal of Allergy and Clinical Immunology 2001;108(4):651-2.
2. Breneman 2000 {published data only} * Breneman DL, Hanifin JM, Berge CA, Keswick BH, Neumann PB. The effect of antibacterial soap with 1.5% triclocarban on Staphylococcus aureus in patients with atopic dermatitis. Cutis 2000;66:296-300.
3. Ewing 1998 {published data only} * Ewing CI, Ashcroft C, Gibbs ACC, Jones GA, Connor PJ, David TJ. Flucloxacillin in the treatment of atopic dermatitis. British Journal of Dermatology 1998;138:1022- 9.
4. Fattah 1976 {published data only} * Fattah AA, El Shiemy S, Faris R. A comparative clinical evaluation of a new topical steroid "Halcinonide" and hydrocortisone in steroid responsive dermatoses. Journal of International Medical Research 1976;4:228-31.
5. Gong 2006 {published data only} * Gong JQ, Lin L, Lin T, Hao F, Zeng FQ, Bi ZG, et al.Skin colonisation by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial. British Journal of Dermatology 2006;155:680-7.
6. Harper 1995 {published data only} * Harper J. Double-blind comparison of an antiseptic oil-based bath additive (Oilatum Plus) with regular Oilatum (Oilatum Emollient) for the treatment of atopic eczema. The bacterology of eczema. The Royal Society of Medicine Press Ltd, 1995.
7. Hizawa 1998 {published data only} * Hizawa T, Sano H, Endo K, Fukuzumi T, Kataoka Y, Aoki T. Is povidone-iodine effective to the lesions of atopic dermatitis. Skin Research 1998;40 (suppl. 20):134-9.
8. Hjorth 1985 {published data only} * Hjorth N, Schmidt H, Thomsen K. Fusidic acid plus betamethasone in infected or potentially infected eczema. Pharmacotheraputica 1985;4(2):126-31.
9. Holland 1995 {published data only} * Holland KT, Bojar RA, Cunliffe WJ. A comparison of the effect of treatment of atopic eczema with and without antimicrobial compounds. The bacteriology of eczema. The Royal Society of Medicine Press Ltd, 1995.
10. Juenger 2006 {published data only} * Juenger M, Ladwig A, Staecker S, Arnold A, Kramer A, Daeschlein G, et al.Efficacy and safety of silver textile in the treatment of atopic dermatitis (AD). Current Medical Research and Opinion 2006;22(4):739-50.
11. Korting 1994 {published data only} * Korting HC, Zienicke H, Braun-Falco O, Boek K, Milbradt R, Nolting S, et al.Modern topical glucocorticoids and anti-infectives for superinfected atopic eczema: do prednicarbate and didecyldimethylammoniumchloride form a rational combination?. Infection 1994;22(6):390-3.
12. Lever 1988 {published data only} * Lever R, Hadley K, Downey D, Mackie R. Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy. British Journal of Dermatology 1988;119:189-98.
13. Leyden 1977 {published data only} * Leyden JJ, Kligman AM. The case for steroid-antibiotic combinations. British Journal of Dermatology 1977;96:179-87.
14. Masako 2005b {published data only} * Masako K, Yusuke K, Hideyuki I, Atsuko M, Yoshiki M, Kayoko M, et al.A novel method to control the balance of skin microflora. Part 2. A study to assess the effect of a cream containing farnesol and xylitol on atopic dry skin. Journal of Dermatological Science 2005;38:207-13.
15. Nilsson 1992 {published data only} * Nilsson EJ, Henning CG, Magnusson J, Sundsvall BS. Topical corticosteroids and Staphylococcus aureus in atopic dermatitis. Journal of the American Academy of Dermatology 1992;27:29-34.
16. Polano 1960 {published data only} * Polano MK, De Vries HR. Analysis of the results obtained in the treatment of atopic dermatitis with corticosteroid and neomycin containing ointments. Dermatologica 1960;120:191-9.
17. Ramsay 1996 {published data only} * Ramsay CA, Savoie JM, Gilbert M, Gidon M, Kidson P. The treatment of atopic dermatitis with topical fusidic acid and hydrocortisone acetate. Journal of the European Academy of Dermatology and Venereology 1996;7(Suppl. 1):S15-S22.
18. Schempp 2003 {published data only} Schempp CM, Hezel S, Simon JC. Topical treatment of atopic dermatitis with St John's wort cream - a randomized, placebo controlled, double blind half-side comparison [Behandlung der subakuten atopischen Dermatitis mit Johanniskraut-Creme. Eine randomisierte, placebokontrollierte Doppelblindstudie im Halbsetendesign]. Hautarzt 2003;54:248-53.
19. * Schempp CM, Windeck T, Hezel S, Simon JC. Topical treatment of atopic dermatitis with St John's wort cream - a randomized, placebo controlled, double blind half-side comparison. Phytomedicine 2003;10 (supplement IV):31-7.
20. Schuttelaar 2005 {published and unpublished data} * Schuttelaar M-LA, Coenraads P-J. A randomised, double-blind study to assess the efficacy of addition of tetracycline to triamcinolone acetonide (class II corticosteroid) in the treatment of moderate to severe atopic dermatitis. Journal of the European Academy of Dermatology 2008; Vol. In press.
21. Wachs 1976 {published data only} * Wachs GN, Maibach HI. Co-operative double-blind trial of an antibiotic/ corticosteroid combination in impetiginized atopic dermatitis. British Journal of Dermatology 1976;95:323-8.
22. Weinberg 1992 {published data only} * Weinberg E, Fourie B, Allmann B, Toerien A. The use of cefadroxil in superinfected atopic dermatitis. Current Theraputic Research 1992;52(5):671-6.
23. Bjornberg 1975 {published data only} Bjornberg A, Hellgren L, Nygren B. Diproderm with Gentamicin - a new very potent steroid ointment in infected eczema. Current Therapeutic Research 1975;18(4):556-8.
24. Breneman 1990 {published data only} Breneman DL. Use of mupiricin ointment in the treatment of secondarily infected dermatoses. Journal of the American Academy of Dermatology 1990;22(5):886-92.
25. Carpenter 1973 {published data only} Carpenter CL, Jolly HW, McCormick GE, Schneiderman RN, Thompson JG. Combined steroid-antiinfective topical therapy in common dermatoses: a double-blind, multicenter study of iodochlorhydroxyquin-hydrocortisone in 277 patients. Current Therapeutic Research 1973;15(9):650-9.
26. Clark 1974 {published data only} * Clark RF. The case for corticosteroid-antibiotic combinations. Cutis 1974;14:737-41.
27. Davis 1968 {published data only} * Davis CM, Fulghum DD, Taplin D. The value of neomycin in a neomycin-steroid cream. JAMA 1968;203:136-8.
28. Eaglstein 1977 {published data only} Eaglstein WH. Systemic antibiotic treatment of secondarily infected dermatitis. Archives of Dermatology 1977;113(10):1378-9.
29. Gauger 2003 {published data only} * Gauger A, Mempel M, Schekatz A, Schafer T, Ring J, Abeck D. Silver-coated textiles reduce Staphylococcus aureus colonization in patients with atopic eczema. Dermatology 2003;207:15-21.
30. GP medical research {published data only} * The G.P. Medical Research Unit. Treatment of eczemas and infected eczemas. The British Journal of Clinical Practice 1967;21(10):505-7.
31. Kimata 1998 {published data only} Kimata H. Effect of nadifloxacin on atopic dermatitis with methicillin-resistant Staphylococcus aureus in young children. European Journal of Pediatrics 1999;158:949-54.
32. Lloyd 1969 {published data only} * Lloyd KM. The value of neomycin in topical corticosteroid preparations. Southern Medical Journal 1969;62:94-6.
33. Masako 2005a {published data only} * Masako K, Hideyuki I, Shigeyuki O, Zenro I. A novel method to control the balance of skin microflora. Part 1. Attack on biofilm of Staphylococcus aureus without antbiotics. Journal of Dermatological Science 2005;38:197-205.
34. Meenan 1988 {published data only} * Meenan FOC. A double-blind comparative study to compare the efficacy of Locoid C with Tri-adcortyl in chldren with infected eczema. The British Journal of Clinical Practice 1988;42:200-2.
35. Remitz 2001 {published data only} * Remitz A, Kyllonen H, Granlund H, Reitamo S. Tacrolimus ointment reduces staphylococcal colonization of atopic dermatitis lesions. Journal of Allergy and Clinical Immunology 2001; Vol. 107, issue 1:196-7.
36. Rist 2001 {published data only} * Rist T, Parish LC, Capin LR, Sulica V, Bushnell WD, Cupo MA. A comparison of the efficacy and safety of mupirocin cream and cepalexin in the treatment of secondarily infected eczema. Clinical and Experimental Dermatology 2002;27:14-20.
37. Salo 1988 {published data only} * Salo OP, Gordin A, Brandt H, Antikainen R. Efficacy and tolerability of erythromycin acistrate and erythromycin stearate in acute skin infections of patients with atopic eczema. Journal of Antimicrobial Chemotherapy 1988;21 (Suppl. D):101-6.
38. Sasai-Takedatsu 1997 {published data only} * Sasai-Takedatsu M, Kojima T, Yamamoto A, Hattori K, Yoshijima S, Taniuchi S, et al.Reduction of Staphylococcus aureus in atopic skin lesions with acid electrolytic water - a new therapeutic strategy for atopic dermatitis. Allergy 1997;52:1012-6.
39. Schempp 2003a {published data only} Schempp CM, Hezel S, Simon JC. Treatment of subacute atopic dermatitis with St John's wort cream [Behandlung der subakuten atopischen Dermatitis mit Johanniskraut-Creme]. Hautarzt 2003;54:248-53.
40. Stalder 1992 {published data only} * Stalder JF, Fleury M, Sourisse M, Allavoine TH, Chalamet C, Brosset P, et al.Comparative effects of two topical antiseptics (chlorhexidine vs KMnO4) on bacterial skin flora in atopic dermatitis. Acta Dermato-Venereologica (Stockholm) 1992;71 Suppl. 176:132-4.
41. Thaci 1999 {published data only} Thaci D, Kokorsch J, Kaufmann R. Fusidic aci/Betamethasone 17-valerate in potentially infected atopic dermatitis. Journal of the European Academy of Dermatology. 1999; Vol. 12, issue 3 (Suppl): S163.
42. Theodoridis 1979 {published data only} Theodoridis A, Vagena A, Sivenas C, Capetanakis J. Evaluation of a topical steroid antibiotic combination (halcinonide-neomycin-amphotericin) in the treatment of cutaneous candidiasis and inflammatory dermatoses. Current Medical Research and Opinion 1979;5(10):766-71.
43. Weitgasser 1983 {published data only} * Weitgasser H, Schindlery C, Macarol V. A comparative multicentre trial of halometasone/triclosan cream and betamethasone diproprionate/ gentamicin sulphate cream in the treatment of infected acute eczematous dermatitis. Journal of International Medical Research 1983;11 Suppl. 1:43-7.
44. Whitefield 1998 {published data only} Whitefield M. Effectiveness of a new antimicrobial emollient in the management of eczema/dermatitis. Journal of Dermatological Treatment 1998;9:103-9.
45. Wilkinson JD 1985 {published data only} * Wilkinson JD, Leigh DA. Comparative efficacy of betamethasone and either fusidic acid or neomycin in infected or potentially infected eczema. Current Therapeutic Research 1985;38:177-82.
46. Wilkinson RD 1980 {published data only} * Wilkinson RD, Collins JP, Raymond GP, Mailhot R, Perras MA, Ricard P. Therapy of infected dermatitis: comparative response to two corticosteroid antimicrobial creams. Journal of the American Academy of Dermatology 1980;2:207-11.
47. Zienicke 1993 {published data only} Zienicke H. Topical glucocorticoids and anti-infectives: a rational combination?. Current Problems in Dermatology 1993;21:186-91.
48. Gauger 2006 {published data only} Gauger A, Fischer S, Mempel M, Schaefer T, Foelster-Holst R, et al.Efficacy and functionality of silver coated textiles in patients with atopic eczema. Journal of the European Academy of Dermatology and Veneriology 2006;20(5):534-41.
49. Huang 2007 {published data only} Huang SH, Lin YT, Chu CY, Lee CC, Liang TC, et al.Staphylococcus colonization in atopic dermatitis treated with fluticasone or tacrolimus with or without antibiotics. Annals of Allergy, Asthma and Immunology 2007;98(1):51-6.
50. Senti 2006 {published data only} Senti G, Steinmann LS, Fischer B, Kurman R, Storni T, Johansen P, et al.Antimicrobial silk clothing in the treatment of atopic dermatitis proves comparable to topical corticosteroid treatment. Dermatology 2006;213(3):228-33.
51. Brown 2002 Brown EM, Thomas P. Fusidic acid resistance in Staphylococcus aureus isolates. The Lancet March 2, 2002;359:803.
52. David 1986 David TJ, Cambridge GC. Bacterial infection and atopic eczema. Archives of Disease in Childhood 1986;61:20-3.
53. El-Zimaity 2004 El-Zimaity D, Kearns AM, Dawson SJ, et al.Survey, characterization and susceptibility to fusidic acid of Staphylococcus aureus in the Carmarthern area. Journal of Antimicrobial Chemotherapy 2004;54: 441-6.
54. Emerson 1997 Emerson RM, Williams HC, Allen BR. Severity distribution of atopic dermatitis in the community and its relationship to secondary referrals. British Journal of Dermatology 1998;139:73-6.
55. Hanifin 1980 Hanifin JM, Rajka G. Diagnostic features of atopic eczema. Acta Dermato-Venerologica (Stockholm) 1980;92:44-7.
56. Higgins 2008 Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Handbook for Systematic Reviews of Interventions. 5.0.0. The Cochrane Collaboration, February 2008.
57. Juni 2001 Juni P, Altman DG, Egger M. Assessing the quality of controlled clinical trials. BMJ 2001;323:42-6.
58. Kay 1994 Kay J, Gawkroger DJ, Mortimer MJ, Jaron AG. The prevalence of childhood atopic eczema in a general population. Journal of the American Academy of Dermatology 1994;30:35-9.
59. Leung 2000 Leung YM. Atopic dermatitis: New insights and opportunities for therapeutic intervention. Journal of Allergy and Clinical Immunology 2000;105(5):860-76.
60. Leyden 1974 Leyden JJ, Marples R, Kligman M. Staphylococcus aureus in the lesions of atopic dermatitis. British Journal of Dermatology 1974;90:525-30.
61. McFadden 1993 McFadden JP, Noble WC, Camp RDR. Superantigenic exotoxin-secreting potential of staphylococci isolated from atopic eczematous skin. British Journal of Dermatology 1993;128:631-2.
62. Neame 1995 Neame RL, Berth-Jones J, Kurinczuk JJ, Graham-Brown RAC. Prevalence of atopic dermatitis in Leicester: a study of methodology and examination of possible ethnic variations. British Journal of Dermatology 1995;132:772-7.
63. NICE 2007 National Collaborating Centre for Women's and Children's health. Atopic eczema in children. Management of atopic eczema in children from birth up to the age of 12 years. National Institute for Clinical Excellence 2007. [: http://www.nice.org.uk/guidance/index.jsp?action=download&o=38559]
64. PCDS 2003 Primary Care Dermatology Society and British Association of Dermatologists. Guidelines on the management of atopic eczema. http://www.bad.org.uk/healthcare/service/Eczema_11.03.03.pdf 2003.
65. Ravenscroft 2000 Ravenscroft JC, Layton A, Barnham M. Observations on high levels of fusidic acid resistant Staphylococcus aureus in Harrogate, North Yorkshire, UK.Clinical and Experimental Dermatology 2000;25:327-30.
66. Reed 1999 Reed J, Lyons M, Waghorn D, Wilkinson J. Fusidic acid resistance rates in South Buckinghamshire. British Journal of Dermatology 1999;141 (Suppl 55):57.
67. Schmitt 2007 Schmitt J, Langan S, Williams HC and the European Dermato-Epidemiology Network. What are the best outcome measurements for atopic eczema?- A systematic review. Journal of Allergy and Clinical Immunology 2007;120:1389-98.
68. Simpson-Dent 2000 Simpson-Dent SL, Hunt SJ, Hardman C, Barrett S, Wakelin SH. Rates of fusidic acid resistance in paediatric dermatology patients - a 6-year study. British Journal of Dermatology 2000;143 (Suppl 57):123-30.
69. Stalder 1994 Stalder JF, Fleury M, Sourisse M, Rostin M, Pheline F, Litoux P. Local steroid therapy and bacterial skin flora in atopic dermatitis. British Journal of Dermatology 1994;131:536-40.
70. Strange 1996 Strange P, Skov L, Lisby S, Nielson PL, Baadsgaard O. Staphylococcal enterotoxin B applied on intact normal and intact atopic skin induces dermatitis. Archives of Dermatology 1996;132:27-33.
71. White 1985 White MI, Noble WC. The cutaneous reaction to staphylococcal protein A in patients with atopic dermatitis or psoriasis. British Journal of Dermatology 1985;113:179-83.
72. Williams 1990 Williams REA, Gibson AG, Aitchison TC, Lever R, Mackie RM. Assessment of a contact-plate sampling technique and subsequent quantitative bacterial studies in atopic dermatitis. British Journal of Dermatology 1990;123:493-501.
73. Williams 1992 Williams HC. Is the prevalence of atopic dermatitis increasing?. Clinical and Experimental Dermatology 1992;17:385-91.
74. Williams 1994 Williams HC, Burney PGJ, Pembroke AC, Hay RH. The UK Working Party's diagnostic criteria for atopic dermatitis. British Journal of Dermatology 1994;131(3):383-96.
75. Williams 1999 Williams H, Robertson C, Stewart A, Ait-Khaled N, Anabwani G, Anderson R, et al.Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood. Journal of Allergy and Clinical Immunology 1999;103(1):125-38.